Insider Trading activities of Exelixis, Inc. (EXEL)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Exelixis, Inc. (EXEL) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Exelixis, Inc. since year 2005. Table 2 shows the detailed insider transactions of Exelixis, Inc. since 2005. The reporting company's ticker symbol is EXEL. The reporting company's CIK number is 939767.
The total value of stock buying since 2005 is $3,904,031.
The total value of stock sales since 2005 is $141,236,548.
The total value of stock option exercises since 2005 is $34,437,559.


 1   2   3   4 
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Exelixis, Inc. (EXEL).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-06 0 $0 68,596 $1,363,227 27,596 $153,433
2019-05 0 $0 169,261 $3,428,231 71,591 $406,832
2019-04 0 $0 246,931 $5,867,758 219,359 $1,203,851
2019-03 0 $0 234,519 $5,489,565 199,700 $1,248,854
2019-02 0 $0 645,973 $14,265,992 373,500 $1,927,504
2019-01 0 $0 191,370 $4,150,602 150,370 $765,267
2018-12 0 $0 53,499 $1,130,148 13,499 $68,034
2018-11 0 $0 158,108 $2,753,786 74,499 $359,974
2018-10 0 $0 49,501 $882,507 24,501 $123,485
2018-09 0 $0 47,500 $838,175 22,500 $123,750
2018-08 0 $0 389,128 $7,858,514 545,100 $1,940,118
2018-07 0 $0 112,500 $2,378,700 112,500 $618,750
2018-06 0 $0 112,500 $2,233,800 112,500 $618,750
2018-05 0 $0 357,974 $7,563,237 212,250 $1,430,233
2018-04 0 $0 119,959 $2,476,869 194,591 $1,145,613
2018-03 0 $0 86,000 $2,075,130 93,293 $813,595
2018-02 0 $0 60,029 $1,615,536 28,625 $224,358
2018-01 0 $0 15,000 $454,515 15,000 $119,550
2017-09 0 $0 897,942 $23,919,083 527,302 $1,918,872
2017-05 0 $0 598,347 $13,258,833 591,860 $2,024,351
2017-04 0 $0 10,000 $213,000 20,090 $205,291
2017-03 0 $0 600,578 $13,508,762 616,257 $4,602,550
2017-02 0 $0 70,000 $1,305,500 70,000 $459,900
2017-01 0 $0 70,000 $1,046,500 70,000 $363,300
2016-12 0 $0 329,726 $5,741,547 485,332 $4,131,934
2016-11 0 $0 292,000 $4,250,500 292,000 $2,364,679
2016-08 0 $0 173,493 $1,905,799 175,000 $1,702,749
2016-06 0 $0 0 $0 200,000 $340,000
2016-05 60,000 $297,920 0 $0 0 $0
2015-12 100,000 $488,549 0 $0 0 $0
2015-11 0 $0 0 $0 5,208 $0
2015-10 0 $0 352,425 $2,055,775 352,425 $1,984,151
2014-11 0 $0 0 $0 11,646 $0
2014-09 20,000 $34,200 0 $0 0 $0
2014-02 0 $0 0 $0 12,268 $0
2013-11 0 $0 0 $0 17,473 $0
2013-08 10,000 $51,400 0 $0 12,266 $0
2013-05 0 $0 0 $0 12,264 $0
2013-02 0 $0 0 $0 12,267 $0
2012-12 35,000 $156,795 0 $0 0 $0
2012-11 0 $0 0 $0 17,474 $0
2012-08 0 $0 0 $0 12,266 $0
2012-06 0 $0 7,000 $35,917 0 $0
2012-05 0 $0 0 $0 12,264 $0
2012-02 0 $0 0 $0 12,267 $0
2011-11 0 $0 0 $0 12,265 $0
2011-08 0 $0 0 $0 14,844 $0
2011-05 0 $0 0 $0 19,842 $0
2011-02 0 $0 0 $0 74,376 $0
2010-12 0 $0 108,539 $835,207 104,427 $570,120
2010-09 36,200 $130,403 0 $0 0 $0
2010-08 446,500 $1,359,351 0 $0 0 $0
2009-12 0 $0 12,500 $98,625 12,500 $63,000
2009-11 0 $0 2,529 $15,657 0 $0
2009-06 0 $0 18,806 $94,165 0 $0
2008-10 392,500 $1,276,125 0 $0 0 $0
2008-03 0 $0 2,213 $11,014 0 $0
2008-02 0 $0 10,000 $65,801 0 $0
2008-01 0 $0 15,000 $111,424 0 $0
2007-12 0 $0 12,500 $111,060 0 $0
2007-11 0 $0 10,000 $93,659 0 $0
2007-10 0 $0 8,125 $97,987 0 $0
2007-07 0 $0 18,125 $212,640 0 $0
2007-06 0 $0 18,125 $211,961 0 $0
2007-05 0 $0 12,500 $140,573 0 $0
2007-04 0 $0 10,000 $107,738 0 $0
2007-03 0 $0 7,500 $72,427 0 $0
2007-02 0 $0 12,500 $132,011 0 $0
2007-01 0 $0 10,000 $96,134 0 $0
2006-12 0 $0 10,000 $91,002 0 $0
2006-11 0 $0 12,500 $108,246 0 $0
2006-10 0 $0 10,000 $96,404 0 $0
2006-09 0 $0 10,000 $91,296 0 $0
2006-08 0 $0 12,500 $107,187 0 $0
2006-07 0 $0 15,000 $139,701 0 $0
2006-06 0 $0 7,500 $75,509 0 $0
2006-05 0 $0 23,124 $244,909 15,624 $99,711
2006-04 0 $0 50,000 $559,354 40,000 $252,000
2006-03 0 $0 32,500 $366,599 10,000 $63,000
2006-02 0 $0 12,500 $127,875 0 $0
2006-01 0 $0 10,000 $106,898 0 $0
2005-12 0 $0 10,000 $90,154 0 $0
2005-11 0 $0 12,500 $104,842 0 $0
2005-10 0 $0 10,000 $74,889 0 $0
2005-09 0 $0 280,458 $2,187,008 0 $0
2005-04 0 $0 7,500 $55,527 0 $0
2005-03 0 $0 5,000 $33,557 0 $0
2004-03 2,800 $24,951 0 $0 0 $0
2004-02 7,200 $60,437 0 $0 0 $0
2002-04 2,000 $23,900 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Exelixis, Inc. insiders (EXEL)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-06-13 Lamb Peter (EVP, Scientific Strategy & CSO) Sale 27,596 20.03 552,747
2019-06-13 Lamb Peter (EVP, Scientific Strategy & CSO) Option Ex 27,596 5.56 153,433
2019-06-10 Haley Patrick J. (Sr. Vice President, Commercial) Sale 1,000 20.23 20,230
2019-06-04 Scangos George A Sale 15,000 20.00 300,000
2019-06-03 Scangos George A Sale 25,000 19.61 490,250
2019-05-29 Morrissey Michael (President and CEO) Option Ex 14,591 7.18 104,763
2019-05-21 Scangos George A Option Ex 15,000 4.57 68,550
2019-05-10 Haley Patrick J. (Sr. Vice President, Commercial) Sale 1,000 19.58 19,580
2019-05-08 Willsey Lance Sale 50,000 20.36 1,018,000
2019-05-08 Morrissey Michael (President and CEO) Sale 42,000 20.15 846,299
2019-05-08 Morrissey Michael (President and CEO) Option Ex 42,000 5.56 233,519
2019-05-03 Senner Christopher J. (EVP and CFO) Sale 36,261 20.70 750,602
2019-05-02 Scangos George A Sale 15,000 20.00 300,000
2019-05-01 Scangos George A Sale 25,000 19.75 493,750
2019-04-24 Morrissey Michael (President and CEO) Sale 40,000 20.75 830,000
2019-04-24 Morrissey Michael (President and CEO) Option Ex 40,000 5.56 222,399
2019-04-10 Haley Patrick J. (Sr. Vice President, Commercial) Sale 1,000 24.04 24,040
2019-04-10 Morrissey Michael (President and CEO) Sale 40,000 24.06 962,400
2019-04-10 Morrissey Michael (President and CEO) Option Ex 40,000 5.56 222,399
2019-04-03 Schwab Gisela (Pres, Prod Dev & Med Aff & CMO) Sale 63,109 25.00 1,577,725
2019-04-03 Schwab Gisela (Pres, Prod Dev & Med Aff & CMO) Option Ex 63,109 7.18 453,122
2019-04-03 Scangos George A Sale 5,000 25.03 125,150
2019-04-01 Hessekiel Jeffrey (EVP and General Counsel) Sale 20,000 24.03 480,600
2019-04-01 Hessekiel Jeffrey (EVP and General Counsel) Option Ex 20,000 1.70 34,000
2019-04-01 Garber Alan M Sale 30,000 23.98 719,550
2019-04-01 Garber Alan M Option Ex 30,000 5.25 157,350
2019-04-01 Scangos George A Sale 40,000 24.02 960,800
2019-04-01 Wyszomierski Jack L Sale 7,822 23.97 187,493
2019-04-01 Wyszomierski Jack L Option Ex 26,250 4.37 114,581
2019-03-29 Poste George Sale 3,860 23.89 92,215
2019-03-29 Poste George Option Ex 15,000 4.57 68,550
2019-03-27 Morrissey Michael (President and CEO) Sale 40,000 23.39 935,600
2019-03-27 Morrissey Michael (President and CEO) Option Ex 40,000 5.56 222,399
2019-03-26 Haley Patrick J. (Sr. Vice President, Commercial) Sale 2,700 23.47 63,369
2019-03-26 Haley Patrick J. (Sr. Vice President, Commercial) Option Ex 2,700 5.18 13,986
2019-03-25 Schwab Gisela (Pres, Prod Dev & Med Aff & CMO) Sale 100,000 23.14 2,314,000
2019-03-25 Schwab Gisela (Pres, Prod Dev & Med Aff & CMO) Option Ex 100,000 7.18 718,000
2019-03-14 Haley Patrick J. (Sr. Vice President, Commercial) Sale 2,000 25.00 50,000
2019-03-14 Haley Patrick J. (Sr. Vice President, Commercial) Option Ex 2,000 1.76 3,520
2019-03-14 Scangos George A Sale 5,000 25.00 125,000
2019-03-13 Morrissey Michael (President and CEO) Sale 40,000 24.52 980,800
2019-03-13 Morrissey Michael (President and CEO) Option Ex 40,000 5.56 222,399
2019-03-11 Haley Patrick J. (Sr. Vice President, Commercial) Sale 959 23.13 22,181
2019-03-01 Scangos George A Sale 40,000 22.66 906,400
2019-02-27 Morrissey Michael (President and CEO) Sale 40,000 22.69 907,600
2019-02-27 Morrissey Michael (President and CEO) Option Ex 40,000 5.56 222,399
2019-02-25 Haley Patrick J. (Sr. Vice President, Commercial) Sale 4,272 22.27 95,137
2019-02-25 Cohen Charles Sale 5,271 22.18 116,910
2019-02-25 Cohen Charles Option Ex 26,250 4.37 114,581
2019-02-22 Marchesi Vincent T Sale 41,250 21.50 886,875
2019-02-22 Marchesi Vincent T Option Ex 41,250 4.88 201,423
2019-02-21 Papadopoulos Stelios Sale 26,250 21.25 557,812
2019-02-21 Papadopoulos Stelios Option Ex 26,250 4.37 114,581
2019-02-20 Willsey Lance Sale 26,250 21.11 554,137
2019-02-20 Willsey Lance Option Ex 26,250 4.37 114,581
2019-02-19 Cohen Charles Sale 48,180 21.48 1,034,906
2019-02-15 Schwab Gisela (Pres, Prod Dev & Med Aff & CMO) Sale 23,000 22.20 510,600
2019-02-15 Schwab Gisela (Pres, Prod Dev & Med Aff & CMO) Option Ex 23,000 5.56 127,879
2019-02-15 Cohen Charles Sale 100,000 22.19 2,219,000
2019-02-14 Feldbaum Carl B Sale 50,500 22.03 1,112,515
2019-02-14 Feldbaum Carl B Option Ex 50,500 5.02 253,661
2019-02-14 Schwab Gisela (Pres, Prod Dev & Med Aff & CMO) Sale 100,000 21.66 2,166,000
2019-02-14 Schwab Gisela (Pres, Prod Dev & Med Aff & CMO) Option Ex 100,000 5.56 556,000
2019-02-14 Morrissey Michael (President and CEO) Sale 40,000 22.52 901,000
2019-02-14 Morrissey Michael (President and CEO) Option Ex 40,000 5.56 222,399
2019-02-14 Cohen Charles Sale 100,000 22.41 2,241,000
2019-02-11 Haley Patrick J. (Sr. Vice President, Commercial) Sale 1,000 21.30 21,300
2019-02-01 Scangos George A Sale 40,000 23.53 941,200
2019-01-30 Morrissey Michael (President and CEO) Sale 40,000 23.12 924,800
2019-01-30 Morrissey Michael (President and CEO) Option Ex 40,000 5.56 222,399
2019-01-16 Morrissey Michael (President and CEO) Sale 40,000 23.60 944,000
2019-01-16 Morrissey Michael (President and CEO) Option Ex 40,000 5.56 222,399
2019-01-10 Haley Patrick J. (Sr. Vice President, Commercial) Sale 3,000 23.77 71,310
2019-01-10 Haley Patrick J. (Sr. Vice President, Commercial) Option Ex 2,000 1.76 3,520
2019-01-09 Haley Patrick J. (Sr. Vice President, Commercial) Sale 1,560 23.50 36,660
2019-01-09 Haley Patrick J. (Sr. Vice President, Commercial) Option Ex 1,560 5.82 9,079
2019-01-08 Haley Patrick J. (Sr. Vice President, Commercial) Sale 2,000 23.00 46,000
2019-01-08 Haley Patrick J. (Sr. Vice President, Commercial) Option Ex 2,000 1.76 3,520
2019-01-08 Garber Alan M Sale 11,250 23.00 258,750
2019-01-08 Garber Alan M Option Ex 11,250 4.16 46,800
2019-01-07 Haley Patrick J. (Sr. Vice President, Commercial) Sale 5,560 21.51 119,595
2019-01-07 Haley Patrick J. (Sr. Vice President, Commercial) Option Ex 5,560 3.79 21,072
2019-01-04 Morrissey Michael (President and CEO) Sale 30,383 20.14 611,913
2019-01-04 Morrissey Michael (President and CEO) Option Ex 30,383 5.56 168,929
2019-01-03 Haley Patrick J. (Sr. Vice President, Commercial) Sale 8,000 19.95 159,600
2019-01-03 Haley Patrick J. (Sr. Vice President, Commercial) Option Ex 8,000 1.76 14,080
2019-01-03 Scangos George A Sale 96 20.00 1,920
2019-01-03 Morrissey Michael (President and CEO) Sale 3,571 20.00 71,420
2019-01-03 Morrissey Michael (President and CEO) Option Ex 3,571 5.56 19,854
2019-01-02 Scangos George A Sale 39,904 19.64 783,714
2019-01-02 Morrissey Michael (President and CEO) Sale 6,046 20.00 120,920
2019-01-02 Morrissey Michael (President and CEO) Option Ex 6,046 5.56 33,615
2018-12-03 Schwab Gisela (Pres, Prod Dev & Med Aff & CMO) Sale 13,499 21.02 283,748
2018-12-03 Schwab Gisela (Pres, Prod Dev & Med Aff & CMO) Option Ex 13,499 5.04 68,034
2018-12-03 Scangos George A Sale 40,000 21.16 846,400
2018-11-30 Senner Christopher J. (EVP and CFO) Sale 8,791 19.70 173,182
2018-11-30 Hessekiel Jeffrey (EVP and General Counsel) Sale 1,943 19.91 38,685
2018-11-30 Scangos George A Sale 8,500 20.00 170,000
2018-11-29 Hessekiel Jeffrey (EVP and General Counsel) Sale 1,116 19.51 21,773
2018-11-29 Scangos George A Sale 6,500 20.00 130,000
2018-11-28 Hessekiel Jeffrey (EVP and General Counsel) Sale 11,759 19.12 224,832
2018-11-15 Morrissey Michael (President and CEO) Sale 25,000 17.22 430,500
2018-11-15 Morrissey Michael (President and CEO) Option Ex 25,000 4.42 110,500
2018-11-07 Haley Patrick J. (Sr. Vice President, Commercial) Sale 20,000 17.32 346,400
2018-11-02 Morrissey Michael (President and CEO) Sale 37,499 18.25 684,244
2018-11-02 Morrissey Michael (President and CEO) Option Ex 37,499 5.04 188,994
2018-11-01 Schwab Gisela (Pres, Prod Dev & Med Aff & CMO) Sale 12,000 14.16 169,920
2018-11-01 Schwab Gisela (Pres, Prod Dev & Med Aff & CMO) Option Ex 12,000 5.04 60,480
2018-11-01 Scangos George A Sale 25,000 14.57 364,250
2018-10-01 Schwab Gisela (Pres, Prod Dev & Med Aff & CMO) Sale 12,000 17.77 213,240
2018-10-01 Schwab Gisela (Pres, Prod Dev & Med Aff & CMO) Option Ex 12,000 5.04 60,480
2018-10-01 Scangos George A Sale 25,000 17.86 446,500
2018-10-01 Morrissey Michael (President and CEO) Sale 12,501 17.82 222,767
2018-10-01 Morrissey Michael (President and CEO) Option Ex 12,501 5.04 63,005
2018-09-24 Scangos George A Sale 25,000 16.85 421,250
2018-09-04 Schwab Gisela (Pres Prod Dev & Med Aff & CMO) Sale 22,500 18.53 416,925
2018-09-04 Schwab Gisela (Pres Prod Dev & Med Aff & CMO) Option Ex 22,500 5.50 123,750
2018-08-20 Morrissey Michael (President and CEO) Sale 90,000 18.20 1,638,000
2018-08-20 Morrissey Michael (President and CEO) Option Ex 90,000 5.50 495,000
2018-08-17 Schwab Gisela (Pres Prod Dev & Med Aff & CMO) Option Ex 50,000 5.51 275,500
2018-08-15 Marchesi Vincent T Sale 40,000 19.50 780,000
2018-08-15 Marchesi Vincent T Option Ex 40,000 3.38 135,200
2018-08-10 Scangos George A Option Ex 108,333 4.73 512,415
2018-08-09 Morrissey Michael (President and CEO) Sale 34,267 20.91 716,522
2018-08-09 Morrissey Michael (President and CEO) Option Ex 34,267 1.70 58,253
2018-08-08 Morrissey Michael (President and CEO) Sale 100,000 21.02 2,102,000
2018-08-08 Morrissey Michael (President and CEO) Option Ex 100,000 1.70 170,000
2018-08-07 Morrissey Michael (President and CEO) Sale 100,000 21.10 2,110,000
2018-08-07 Morrissey Michael (President and CEO) Option Ex 100,000 1.70 170,000
2018-08-06 Haley Patrick J. (Sr. Vice President, Commercial) Sale 2,361 20.92 49,392
2018-08-01 Schwab Gisela (Pres Prod Dev & Med Aff & CMO) Sale 22,500 20.56 462,600
2018-08-01 Schwab Gisela (Pres Prod Dev & Med Aff & CMO) Option Ex 22,500 5.50 123,750
2018-07-16 Morrissey Michael (President and CEO) Sale 90,000 21.13 1,901,700
2018-07-16 Morrissey Michael (President and CEO) Option Ex 90,000 5.50 495,000
2018-07-02 Schwab Gisela (Pres Prod Dev & Med Aff & CMO) Sale 22,500 21.20 477,000
2018-07-02 Schwab Gisela (Pres Prod Dev & Med Aff & CMO) Option Ex 22,500 5.50 123,750
2018-06-25 Morrissey Michael (President and CEO) Sale 90,000 19.62 1,765,800
2018-06-25 Morrissey Michael (President and CEO) Option Ex 90,000 5.50 495,000
2018-06-01 Schwab Gisela (Pres Prod Dev & Med Aff & CMO) Sale 22,500 20.80 468,000
2018-06-01 Schwab Gisela (Pres Prod Dev & Med Aff & CMO) Option Ex 22,500 5.50 123,750
2018-05-31 Hessekiel Jeffrey (EVP and General Counsel) Sale 65,000 20.71 1,346,150
2018-05-30 Feldbaum Carl B Sale 34,262 20.60 705,797
2018-05-30 Feldbaum Carl B Option Ex 14,750 4.37 64,383
2018-05-24 Morrissey Michael (President and CEO) Sale 90,000 20.55 1,849,500
2018-05-24 Morrissey Michael (President and CEO) Option Ex 90,000 5.50 495,000
2018-05-22 Willsey Lance Sale 50,000 21.40 1,070,000
2018-05-18 Haley Patrick J. (Sr. Vice President, Commercial) Sale 3,663 21.61 79,157
2018-05-15 Scangos George A Option Ex 15,000 11.66 174,900
2018-05-11 Marchesi Vincent T Sale 15,000 19.03 285,450
2018-05-11 Marchesi Vincent T Option Ex 15,000 11.66 174,900
 1   2   3   4 

Insider trading activities including stock purchases, stock sales, and option exercises of EXEL listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Exelixis, Inc. (symbol EXEL, CIK number 939767) see the Securities and Exchange Commission (SEC) website.